Response
We are pleased that Dr van Veldhuisen and colleagues found our study of interest. 1 Although we speculated in our paper that the beneficial effects of statins on cardiac function in patients with idiopathic dilated cardiomyopathy may be due to improvements in endothelial function, neurohormonal imbalance, and inflammation, we agree that another potential mechanism may be due to improvement in myocardial blood flow (MBF) reserve. In experimental animals, we have found that statins upregulate coronary vascular endothelial nitric oxide production 2 and decrease myocardial oxygen consumption. 3 These effects could be the basis for the observed improvement in MBF reserve in hypercholesterolemic subjects with idiopathic dilated cardiomyopathy treated with statins.
We would like to emphasize, however, that improvements in cardiac function with statin treatment probably occur independently of cholesterol lowering. Indeed, we have recently found that statins increase myocardial capillary density in normal and cardiomyopathic Syrian hamsters without significant alterations in serum cholesterol levels. 4 This may reflect a preservation of the coronary microvasculature due to a direct vascular protective effect of statins and is consistent with recent studies demonstrating direct angiogenic effect of statins on ischemic limb vasculature. 5 The ability of statins, therefore, to positively affect the coronary microvasculature may contribute, in part, to the observed improvements in MBF reserve and myocardial function in patients with heart failure.
